RNA-Targeted Drug Discovery Summit 2018

When:
Monday, Dec 03, 2018 8:00a -
Wednesday, Dec 05, 2018 6:00p

Where:
DoubleTree Suites by Hilton Hotel Boston - Cambridge
400 Soldiers Field Road
Boston, MA 02134

EventScheduled OfflineEventAttendanceMode

Admission:
$3398

Categories:
Lectures & Conferences

Event website:
https://go.evvnt.com/271645-3?pid=5248

With our increased understanding of RNA structure and function, and RNA-small molecule binding behaviour a plethora of previously undruggable targets are opening up.


As such, I wanted to introduce to you to the 1st RNA-Targeted Drug Discovery Summit 2018 (Boston, MA - December 3-6, 2018) - a niche scientific and networking forum, carefully curated from those at large pharma, biotech and academia who are pioneering the next generation of small molecule drug discovery.


The 1st RNA-Targeted Drug Discovery Summit will bring together a unique community of experts, devoted to optimizing the process of discovering and designing small molecules that bind specifically to quality RNA targets and translating these into clinically safe and effective therapies. Sounds interesting? Get your free event brochure copy to find out more: http://bit.ly/2C7derg


Meet with experts and come away with:
- Deep understanding of how to translate the structure, dynamics and function of RNA into lead small molecules with insights from Matthew Disney, Founder, Expansion Therapeutics & Professor, Scripps Research Institute. Explore experimental approaches that support target engagement in cells to support compound mode of action.
- Explore the discovery, structure and cellular activity of small molecule inhibitors of cellular and viral RNAs through the insights delivered by Gabriele Varani, Professor of Chemistry, University of Washington.
- Understand principles for targeting RNA with small molecules with perspectives from Kevin Weeks, Professor, UNC to help structure your research into targeting RNA


I hope you can join this rapidly emerging community in Boston this December in order to overcome the target identification and validation, selective binding and chemistry challenges facing those trying to translate novel small molecules that successfully target therapeutically relevant RNA, and accelerate them into the clinic.


Brochure https://go.evvnt.com/271645-0?pid=5248
Tickets https://go.evvnt.com/271645-1?pid=5248


Prices:
Full Price - Industry - Conference + Workshop (check website for Early Bird Discounts) USD 3398.0
Full Price - Academia - Conference + Workshop (check website for Early Bird Discounts) USD 2298.0


Speakers: Matthew Disney, Founder, Expansion Therapeutics & Professor, Scripps Research Institute, Kevin Weeks, Professor, UNC, Matt Woll, Senior Director of Chemistry, PTC Therapeutics, Anne Boriack-Sjodin, VP of Molecular Discovery, Accent Therapeutics, Razvan Nutiu, Investigator III, Novartis , Benjamin Miller, Principal Investigator, URMC, Jennifer Petter, Founder & CSO, Arrakis Therapeutics, Gabriele Varani, Professor of Chemistry, University of Washington

Share this event

Add to:

Reddit
12/03/2018 08:00:00 12/05/2018 18:00:00 America/New_York RNA-Targeted Drug Discovery Summit 2018 With our increased understanding of RNA structure and function, and RNA-small molecule binding behaviour a plethora of previously undruggable targets are opening up. As such, I wanted to introdu... DoubleTree Suites by Hilton Hotel Boston - Cambridge, Boston, MA 02134 false MM/DD/YYYY

Sponsored events